安慰剂
医学
科克伦图书馆
荟萃分析
萧条(经济学)
汉密尔顿抑郁量表
贝克抑郁量表
内科学
随机对照试验
不利影响
评定量表
传统医学
精神科
重性抑郁障碍
替代医学
心理学
焦虑
经济
宏观经济学
发展心理学
病理
扁桃形结构
作者
Rui‐Feng Yang,You Wu,Lindong Zhang,Lili Wu,Lingling Qin,Tonghua Liu
摘要
ABSTRACT Depression is prevalent in type 2 diabetes mellitus (T2DM) patients, and herbal products may be used as alternative therapies for this comorbidity. We conducted a meta‐analysis to analyze the efficacy and safety of herbal product‐related randomized controlled trials (RCTs) for patients with T2DM and depression. Scopus, Cochrane Library, Clinicaltrials.gov , Embase, PubMed, Ovid, Web of Science, China National Knowledge Infrastructure (CNKI), Chongqing VIP, SinoMed, and WanFang databases were retrieved from inception to September 2023 to collect RCTs that compared herbal products to placebo and selective serotonin reuptake inhibitors (SSRIs). The risk of bias assessments and a meta‐analysis were conducted using Review Manager 5.4 and Stata 15.0. The study included 15 studies containing 16 trials. Our analyses revealed that herbal products were more effective than placebo in reducing the Hamilton Rating Scale for Depression—24 items (HRSD‐24) (MD = −5.98, 95% CI [−7.92, −4.04], p < 0.00001, I 2 = 0%) and the Beck Depression Inventory‐II (BDI‐II) scores. Herbal products combined with SSRIs were better than SSRIs alone in decreasing the Hamilton Rating Scale for Depression—17 items (HRSD‐17), HRSD‐24, and self‐rating depression scale (SDS) scores. The incidence of adverse events associated with herbal products was comparable to that observed with placebo and SSRIs. For patients with T2DM and depression, herbal products were more effective than placebo in relieving depression symptoms. Additionally, herbal products combined with SSRIs alleviated depression and blood glucose levels more effectively than SSRIs alone. To verify the clinical efficacy of herbal products, high‐quality studies are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI